Annual Total Long Term Liabilities
$58.16 M
-$9.88 M-14.51%
December 1, 2024
Summary
- As of March 12, 2025, TRDA annual total long term liabilities is $58.16 million, with the most recent change of -$9.88 million (-14.51%) on December 1, 2024.
- During the last 3 years, TRDA annual total long term liabilities has risen by +$57.77 million (+14587.12%).
- TRDA annual total long term liabilities is now -28.77% below its all-time high of $81.66 million, reached on December 31, 2020.
Performance
TRDA Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$58.16 M
-$3.38 M-5.49%
December 1, 2024
Summary
- As of March 12, 2025, TRDA quarterly total long term liabilities is $58.16 million, with the most recent change of -$3.38 million (-5.49%) on December 1, 2024.
- Over the past year, TRDA quarterly long term liabilities has stayed the same.
- TRDA quarterly long term liabilities is now -70.62% below its all-time high of $197.99 million, reached on June 30, 2021.
Performance
TRDA Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
TRDA Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -14.5% | 0.0% |
| 3 y3 years | +10000.0% | +231.8% |
| 5 y5 years | +82.7% | +231.8% |
TRDA Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -14.5% | >+9999.0% | -63.9% | >+9999.0% |
| 5 y | 5-year | -28.8% | >+9999.0% | -70.6% | >+9999.0% |
| alltime | all time | -28.8% | >+9999.0% | -70.6% | >+9999.0% |
Entrada Therapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $58.16 M(-14.5%) | $58.16 M(-5.5%) |
| Sep 2024 | - | $61.54 M(-7.1%) |
| Jun 2024 | - | $66.23 M(-1.9%) |
| Mar 2024 | - | $67.54 M(-0.7%) |
| Dec 2023 | $68.04 M(+288.1%) | $68.04 M(-6.7%) |
| Sep 2023 | - | $72.94 M(-54.7%) |
| Jun 2023 | - | $161.13 M(+63.8%) |
| Mar 2023 | - | $98.36 M(+461.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $17.53 M(+4326.8%) | $17.53 M(-11.0%) |
| Sep 2022 | - | $19.69 M(-9.7%) |
| Jun 2022 | - | $21.80 M(-8.7%) |
| Mar 2022 | - | $23.89 M(+5931.6%) |
| Dec 2021 | $396.00 K(-99.5%) | $396.00 K(-99.8%) |
| Sep 2021 | - | $197.83 M(-0.1%) |
| Jun 2021 | - | $197.99 M(+142.5%) |
| Dec 2020 | $81.66 M(+156.5%) | $81.66 M |
| Dec 2019 | $31.84 M | - |
FAQ
- What is Entrada Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Entrada Therapeutics?
- What is Entrada Therapeutics annual total long term liabilities year-on-year change?
- What is Entrada Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Entrada Therapeutics?
- What is Entrada Therapeutics quarterly long term liabilities year-on-year change?
What is Entrada Therapeutics annual total long term liabilities?
The current annual total long term liabilities of TRDA is $58.16 M
What is the all time high annual total long term liabilities for Entrada Therapeutics?
Entrada Therapeutics all-time high annual total long term liabilities is $81.66 M
What is Entrada Therapeutics annual total long term liabilities year-on-year change?
Over the past year, TRDA annual total long term liabilities has changed by -$9.88 M (-14.51%)
What is Entrada Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of TRDA is $58.16 M
What is the all time high quarterly long term liabilities for Entrada Therapeutics?
Entrada Therapeutics all-time high quarterly total long term liabilities is $197.99 M
What is Entrada Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, TRDA quarterly total long term liabilities has changed by $0.00 (0.00%)